✦ LIBER ✦

410 24-WEEK TREATMENT WITH CTS-1027 IN COMBINATION WITH RIBAVIRIN REDUCES HCV-RNA IN TREATMENT NAIVE GENOTYPE-1 PATIENTS

✍ Scribed by M. Chojkier; G. Everson; A. Muir; B. Bacon; M. Rodriguez-Torres; M. Bennett; M. Fried; S. Gordon; J. Gross; D. Nelson; L. Balart; M. Jonas; G. Szabo; J. Bloomer; A. McCullough; L. Nyberg; C. Smith; O. Bohm; A.W. Fox; E. Castelloe; M. Huyghe; S. Mento; A. Spada

Book ID: 117379555
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 81 KB
Volume: 54
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(11)60412-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

All-oral combination of ledipasvir, vedr

All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-naïve patients with genotype 1 HCV infection

✍ Wyles, David L.; Rodriguez-Torres, Maribel; Lawitz, Eric; Shiffman, Mitchell L.; 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 593 KB

1412 INTERFERON-FREE TREATMENT WITH A CO

1412 INTERFERON-FREE TREATMENT WITH A COMBINATION OF MERICITABINE AND DANOPREVIR/R WITH OR WITHOUT RIBAVIRIN IN TREATMENT-NAIVE HCV GENOTYPE 1-INFECTED PATIENTS

✍ Gane, E.J.; Pockros, P.; Zeuzem, S.; Marcellin, P.; Shikhman, A.; Bernaards, C.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Telaprevir with peginterferon and ribavi

Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan

✍ Hiromitsu Kumada; Joji Toyota; Takeshi Okanoue; Kazuaki Chayama; Hirohito Tsubou 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 792 KB

Response-Guided Therapy With Boceprevir

Response-Guided Therapy With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin Reduces Treatment Duration in NaïVE and Peginterferon Alfa-2B/Ribavirin Previous-Treatment-Failure Patients With HCV Genotype 1

✍ Manns, Michael P. ;Poordad, Fred ;Bacon, Bruce R. ;Bruno, Savino ;Esteban, Rafae 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 258 KB

[604] COMPARISON OF A SHORTENED RIBAVIRI

[604] COMPARISON OF A SHORTENED RIBAVIRIN TREATMENT VS A 24 WEEK STANDARD COMBINATION THERAPY IN HCV INFECTED PATIENTS WITH GENOTYPE 2/3

✍ B. Kallinowski; K. Stein; W. Boecher; T. Goeser; U. Spengler; R. Link; H. Klinke 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 276 KB

O111 SAFETY AND EFFICACY OF TREATMENT WI

O111 SAFETY AND EFFICACY OF TREATMENT WITH THE INTERFERON-FREE, RIBAVIRIN-FREE COMBINATION OF SOFOSBUVIR + GS-5816 FOR 12 WEEKS IN TREATMENT NAIVE PATIENTS WITH GENOTYPE 1–6 HCV INFECTION

✍ Everson, G.T.; Tran, T.T.; Towner, W.J.; Davis, M.N.; Wyles, D.; Nahass, R.; McN 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 87 KB